Vaccines are a modern miracle, saving an estimated 154 million lives in the last half-century. Vaccine skepticism is a ...

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. The Department of Health, NHS England ...

Successful early asset development relies on considering the clinical, patient and commercial elements of value collectively, says Jason McDonough. One of the greatest challenges in the early ...

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the emerging ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial.

President Trump has withdrawn his nomination of Dave Weldon to lead the CDC, hours before he was to appear in front of a Senate confirmation hearing.

In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will support its vision of developing multiple personalised therapies for ...

The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics for uncomplicated urinary tract infections (uUTIs) in over 20 years.

President Trump has withdrawn his nomination of Dave Weldon to lead the CDC, hours before he was to appear in front of a Senate confirmation hearing. Grifols has been awarded a $21m grant from the ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products and could be used to respond to an emerging pandemic ...

The pharmaceutical industry is undergoing a profound transformation, driven by the increasing complexity of drug development and the need for greater efficiency and cost-effectiveness. At the ...